Balancing the Pros, Cons of Weight-Loss Drug Coverage

Weight-loss drugs took the world by storm in 2023, and employers who sponsor health plans have been forced to consider whether offering coverage makes sense for their organization in the new year. As demand continues to rise for drugs such as Ozempic and Wegovy, a number of pros and cons have emerged that complicate the decision.

With a high price tag of $1,000 or more out of pocket, Chris O'Shea explains many employers may not be able to shoulder the expense of covering weight-loss drugs. However, those with a larger budget may find the recruiting advantage outweighs the cost. As a barrier to coverage, some employers are requiring health plan members to first participate in a lifestyle program before being allowed coverage.

"When coupled with the fact that these drugs are not designed for short-term use, employers must consider whether their budget can account for long-term coverage."

Interested in learning more? Check out the full article on BenefitsPRO.